Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Hunninghake

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Postgraduate Medicine|January 1, 1970
Drug interactionsD B Hunninghake
American Pharmacy|November 1, 1987
The pharmacology and therapeutics of lipid-lowering drugsD B Hunninghake
The American Journal of Cardiology|December 22, 1998
Is aggressive cholesterol control justified? Review of the post-coronary artery bypass graft trialD B Hunninghake
The Medical Clinics of North America|January 1, 1994
Diagnosis and treatment of lipid disordersD B Hunninghake
The American Journal of Medicine|April 29, 1998
Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapyD B Hunninghake
The American Journal of Cardiology|September 16, 1998
Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studiesD B Hunninghake
Clinical Cardiology|June 22, 1999
Pharmacologic management of triglyceridesD B Hunninghake
Cleveland Clinic Journal of Medicine|November 1, 1993
Which patients need aggressive lipid-altering therapy?D B Hunninghake
Postgraduate Medicine|April 1, 1972
Variable drug responses in manD B Hunninghake
American Heart Journal|February 1, 1991
Effects of celiprolol and other antihypertensive agents on serum lipids and lipoproteinsD B Hunninghake
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Postgraduate Medicine|January 1, 1970
Drug interactionsD B Hunninghake
American Pharmacy|November 1, 1987
The pharmacology and therapeutics of lipid-lowering drugsD B Hunninghake
The American Journal of Cardiology|December 22, 1998
Is aggressive cholesterol control justified? Review of the post-coronary artery bypass graft trialD B Hunninghake
The Medical Clinics of North America|January 1, 1994
Diagnosis and treatment of lipid disordersD B Hunninghake
The American Journal of Medicine|April 29, 1998
Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapyD B Hunninghake
The American Journal of Cardiology|September 16, 1998
Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studiesD B Hunninghake
Clinical Cardiology|June 22, 1999
Pharmacologic management of triglyceridesD B Hunninghake
Cleveland Clinic Journal of Medicine|November 1, 1993
Which patients need aggressive lipid-altering therapy?D B Hunninghake
Postgraduate Medicine|April 1, 1972
Variable drug responses in manD B Hunninghake
American Heart Journal|February 1, 1991
Effects of celiprolol and other antihypertensive agents on serum lipids and lipoproteinsD B Hunninghake
Pageof 14